Scalable brain stimulation for clinical routine

Sooma tDCS™ is the first EU MDR-approved tDCS system — a safe, drug-free, non-invasive treatment for depression and chronic pain. Administered in-clinic or at home under remote supervision as alternative or in-combination with medication.

Professional – Book a demo

For patients

Depression treatment

The next evolution in treating depression is here. Sooma tDCS is a revolutionary noninvasive brain stimulation treatment that effectively relieves patient symptoms – as well as patient queues at the clinic.

Pain management

Chronic pain conditions typically involve a complex array of symptoms – to which Sooma tDCS brain stimulation is the simple, innovative, and drug-free solution. Help the brain drive the pain away.

Dr. Ulrike Vogelmann, Managing Senior Physician at the Department of Psychiatry and Psychotherapy at the Technical University of Munich, shares her experience with Sooma tDCS and the difference it has made for her patients.

What is Sooma tDCS™?

Sooma tDCS combines pioneering brain stimulation technology with remote management in one easy-to-use system for effective data-driven clinical care.

Delivered through a portable device, the treatment utilizes transcranial direct current stimulation (tDCS) to relieve symptoms. It’s noninvasive, drug-free, and proven effective.

Improvement of symptoms typically within 3 weeks

without systemic side effects

Safe, high-quality, and scalable care

through a cost-effective solution

Increased patient flows and shorter queues

via optimized resources and remote care

Easy adoption and onboarding

with simple treatment protocols and user training

Explore Sooma tDCS™ system

Results by the numbers

30,000+

patients treated in more than 35 countries

55%

of patients experienced relief in as little as 3 weeks in large peer-reviewed study*

300+

hospitals and clinics providing Sooma tDCS treatment

500,000+

treatment sessions administered worldwide for both research and patient care

* Lõokene M, Markov N, Nikander M, Neuvonen T, Dilkov D. Reduction of symptoms in patients with major depressive disorder after transcranial direct current stimulation treatment: A real-world study. Journal of Affective Disorders Reports, Volume 8, 2022. https://doi.org/10.1016/j.jadr.2022.100347.

What do clinicians and patients think?

Sooma tDCS has helped thousands of patients find relief and a better quality of life. But don’t just take our word for it – read what clinicians and patients have to say about the benefits of our noninvasive brain stimulation treatment.

More testimonials

“I see tDCS as an effective and safe treatment method in psychiatry, and I am more than convinced that this method has a bright future ahead of it.”

Dr. Margus Lõokene

Medical Doctor and Psychiatrist

Read the story

“At the beginning of the fourth week, there was a clear change in my mood for the better. My sleep pattern had also changed. In fact, the change had already started at the end of the previous week, but I realized it only now.”

65-year-old male patient

Read the story

1/1

Research with Sooma tDCS™

Sooma collaborates with researchers globally to improve patient care across multiple indications. Our fully remote FDA trial is currently recruiting patients with major depressive disorder in the US.

Learn more about ongoing research with Sooma